ODI Pharma AB (publ) (NGM:ODI)

Sweden flag Sweden · Delayed Price · Currency is SEK
1.620
+0.100 (6.58%)
At close: Aug 11, 2025
6.58%
Market Cap30.43M
Revenue (ttm)10.57M
Net Income (ttm)-5.59M
Shares Out18.33M
EPS (ttm)-0.35
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1,845
Average Volume20,499
Open1.520
Previous Close1.520
Day's Range1.500 - 1.650
52-Week Range1.430 - 5.950
Beta0.59
RSI46.57
Earnings DateAug 28, 2025

About ODI Pharma AB

ODI Pharma AB (publ), a pharmaceutical company, engages in the production and distribution of pharmaceutical cannabis and cosmetics products in Europe. It offers dried flowers; and cosmetics products under the Kandol brand. The company was founded in 2018 and is based in Stockholm, Sweden. [Read more]

Industry Pharmaceutical Preparations
Founded 2018
Employees 1
Stock Exchange Nordic Growth Market
Ticker Symbol ODI
Full Company Profile

Financial Performance

In 2024, ODI Pharma AB's revenue was 22.29 million, an increase of 15880.34% compared to the previous year's 139,457. Losses were -568,059, -91.77% less than in 2023.

Financial Statements

News

There is no news available yet.